However, in the case of colon cancers with known deletions in the APC (adenomatous polyposis coli) tumor suppressor gene, PPARγ agonists appear to promote tumor growth, and increase the number of colon polyps, possibly by increasing the uptake of dietary fat (21). Here, APC is linked to intestinal disorder.